BOSENTAN FOR THE TREATMENT OF SKIN ULCERS IN DIABETIC MICROANGIOPATHY [Bosentan zur Behandlung von Hautulzera bei diabetischer Mikroangiopahtie]

Trial Profile

BOSENTAN FOR THE TREATMENT OF SKIN ULCERS IN DIABETIC MICROANGIOPATHY [Bosentan zur Behandlung von Hautulzera bei diabetischer Mikroangiopahtie]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2012

At a glance

  • Drugs Bosentan (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top